Performance evaluation of the new rapid fertility assays in whole blood and plasma on PATHFAST.

Background: The purpose of this study was to evaluate the validity of the PATHFAST fertility marker assays for the rapid measurement of female hormones including: LH, FSH, Estradiol (E2), Progesterone (P4), Prolactin (PRL), and HCG. As for the PATHFAST fertility marker assays, female hormones can be measured by whole blood, plasma, and serum.

Methods: The correlation of the heparin whole blood and the plasma samples in the PATHFAST was examined.